Discover 511 paid clinical trials in New Orleans, Louisiana. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Location: Marrero LA, Webster TX, Garland TX, Cedar Park TX,
Sponsor: Spyre Therapeutics, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07012395
Phase2, Recruiting
Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma
for
Sarcoma
Location: New Orleans LA, Jackson MS, Pensacola FL, Birmingham AL,
Sponsor: University of Leicester
Sex: All
Age: 0 - 49
Code: NCT00020566
Phase3, Recruiting
New
Testing the Combination of Anti-Cancer Drugs, Botensilimab (AGEN1181) and Balstilimab (AGEN2034), After Standard Treatment for Colorectal Cancer, Combat Trial
for
Colorectal Adenocarcinoma, Stage II Colorectal Cancer AJCC v8,
Location: New Orleans LA
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07551596
Phase2, Recruiting
A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
for
Chronic Inflammatory Demyelinating Polyneuropathy
Location: New Orleans LA, Beaumont TX, Homewood AL, Houston TX,
Sponsor: Sanofi
Sex: All
Age: 18+
Code: NCT06290141
Phase3, Recruiting
Effect of Intravenous Acetadote on Incidence of Contrast Induced Nephropathy
for
Nephropathy
Location: New Orleans LA
Sponsor: Ochsner Health System
Sex: All
Age: 18+
Code: NCT00939913
Recruiting
Single vs. Dual-DCCV in Obese Patients
for
Atrial Fibrillation
Location: New Orleans LA, Gretna LA, Shreveport LA
Sponsor: Dr. Daniel P Morin, MD MPH FHRS
Sex: All
Age: 18+
Code: NCT04539158
Recruiting
A Study of Lorigerlimab in Participants With Advanced Solid Tumors
for
Platinum-resistant Ovarian Cancer,
Location: New Orleans LA, Houston TX, San Antonio TX, Madison WI,
Sponsor: MacroGenics
Sex: Female
Age: 18+
Code: NCT06730347
Phase2, Recruiting
Safety, Tolerability, and Efficacy of AXA1125 in NASH With Fibrosis
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)